Session 9: Mood and Anxiety Disorders 2016: Pharmacotherapeutic and Other Advances (Aug 8-12)

Egg Harbor, WI US
August 8, 2016 to August 12, 2016

This symposium will provide clinicians with an overview and update on both conventional and novel treatment approaches to depressive and bipolar disorders, social anxiety disorder, panic disorder, OCD, and PTSD.  Additional foci will be on suicidality, chronic pain, herbal psychopharmacology, computer therapies, and assessment based care.  The symposium will integrate case discussions and the informal exchange of information between faculty and participants.

Monday Dr. Jefferson: Depressive disorders: Neurobiology, pharmacologic profiles, comparative efficacies; Side effects and management; Drug interactions; Treatment resistance

Tuesday Dr. Katzelnick:  Social anxiety and panic disorder; Pros and cons of benzodiazepines; Non-pharmacologic treatment alternatives; Adjunctive therapies

Wednesday Dr. Greist:  Obsessive-compulsive disorder and PTSD; Factors affecting suicidality and its assessment

Thursday Dr. Jefferson:  Bipolar spectrum concept; Controversies; Comorbidity; Managing mania and bipolar depression; Mood stabilizer pharmacology, side effects, and drug interactions

Friday Drs. Jefferson, Katzelnick, and Greist: Herbal psychopharmacology; Integration of measurement-based care; Computer therapies for depression and OCD that improve practices and patient outcomes

Accreditation and Designation of Credit:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this live activity for a maximum of 15 AMA PRA Category 1 Creditstm. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Medical College of Wisconsin designates this activity for up to 15 hours of participation for continuing education for allied health professionals.

The Medical College of Wisconsin is approved by the American Psychological Association to sponsor continuing education for psychologists. MCW maintains responsibility for this program and its content. This activity contains content or processes that may be potentially stressful.

The Medical College of Wisconsin is registered with the Illinois Department of Professional Regulation as a Continuing Education Sponsor for social workers (license number 159-000664).

Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

Tuition includes course materials and continental breakfast.

Purchase an additional 5 DAY session and receive a $100.00 discount. Use coupon code: +DCSI
 

Please note: A $10.00 non-refundable processing fee is assessed on registrations.

 
 

Target Audience

This advanced seminar is geared to mental health and health professionals.

Learning Objectives

  1. Review and update pharmacological treatment approaches to depressive, bipolar, and anxiety disorders
  2. Learn evidence-based approaches to overcoming treatment resistance
  3. Identify risk factors for suicide and assessment of risk
  4. Integrate measurement-based care into clinical practice
Additional information

CME Coordinator Contact Information

Name: 
Brenda Konczal
Phone Number: 
+1 (414) 955-7250
Course summary
Available credit: 
  • 15.00 AAFP
    AAFP credit.
  • 15.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 15.00 APA
    APA credit.
  • 15.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/31/2016
Course expires: 
12/31/2016
Event starts: 
08/08/2016 - 9:00am
Event ends: 
08/12/2016 - 12:15pm
Cost:
$10.00
The Landmark Resort and Conference Center
4929 Landmark Drive
Egg Harbor, WI 54209
United States

The Landmark Resort


4929 Landmark Drive
Egg Harbor, Wisconsin 54209
Reservations (800) 273-7877
E-mail: stay@thelandmarkresort.com
http//:www.thelandmarkresort.com

 

John Greist, MD, and James Jefferson, MD, are Distinguished Senior Scientists at the Madison Institute of Medicine and Clinical Adjunct Professors of Psychiatry at the University of Wisconsin School of Medicine and Public Health. They are, respectively, CEO and President of Healthcare Technology Systems. David Katzelnick, MD, is Chair of the Division of Integrated Behavioral Health and Associate Professor at the Mayo Clinic in Rochester, MN.

Their major clinical and research interests are mood and anxiety disorders, psychopharmacology, CBT, treatment of mental illness in primary care, and the application of computer-based technology in clinical and research settings. They authored and co-authored numerous articles in journals, book chapters, patient education booklets, and books in their areas of expertise.  They continue involvement in professional education through CME conferences.

John Greist, MD, has the following financial disclosures:
Principal, Healthcare Technology Systems, Inc.
Royalties, ERT and Perspective for computer administered self-report assessments and Waypoint Health for self-help computer administered CBT programs for depression and OCD
Consultant, Pfizer, Otsuka
 
James Jefferson, MD, has the following financial disclosures:
Stock Shareholder, BMS, GSK, SciClone
Principal, Healthcare Technology Systems, Inc.
Royalties, ERT and Perspective for computer administered self-report assessments and Waypoint Health for self-help computer administered CBT programs for depression and OCD
 
David Katzelnick, MD, has the following financial disclosures:
Healthcare Technology Systems, Inc., Shareholder and Royalties

Available Credit

  • 15.00 AAFP
    AAFP credit.
  • 15.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 15.00 APA
    APA credit.
  • 15.00 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
03/31/2016
Course expires: 
12/31/2016

Price

Cost:
$10.00
Please login or register to take this course.